GSK2256098

Basic Information

CAS ID: 1224887-10-8
Molecular Formula: C20H23ClN6O2
Molecular Weight: 414.9 g/mol
Monoisotopic Mass: 414.157 g/mol
Class: Small Molecule
Natural Product: No
Other Names:
Analysis: Drug repositioning mechanism analysis

N N NH N NH O NH O Cl

Compound Structure and Identifier

InChI: InChI=1S/C20H23ClN6O2/c1-12(2)27-19(9-13(3)25-27)24-18-10-17(15(21)11-22-18)23-16-8-6-5-7-14(16)20(28)26-29-4/h5-12H,1-4H3,(H,26,28)(H2,22,23,24) See All
InChI Key: BVAHPPKGOOJSPU-UHFFFAOYSA-N
Smiles: CC1=NN(C(=C1)NC2=NC=C(C(=C2)NC3=CC=CC=C3C(=O)NOC)Cl)C(C)C See All
Molfile: Download

Related Target

Related Fibrosis Property

Trial Record 1

ClinicalTrial ID NCT01138033 Disease Fibrosis
Phase Phase 1 Status Completed
First Received June 7, 2010 Last Verified May 11, 2017
Sponsor GlaxoSmithKline

Related Link

PubChem: 46214930
ChEMBL: